Walgreens Boots Alliance (WBA) Lowers FY EPS Guidance to $4-$4.05 from $4.45-$4.65
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
CVS Health (CVS) Trades Lower in Sympathy Following Results from Walgreens (WBA)
June 27, 2023 7:11 AM EDTCVS Health (NYSE: CVS) Trades Lower in Sympathy Following Results from Walgreens (NASDAQ: WBA)
Walgreens revises full-year adjusted EPS guidance to $4.00 to $4.05 from $4.45 to $4.65, to reflect consumer and category conditions, lower COVID-19 contribution, and a more cautious macroeconomic forward viewWBA -7%CVS -2%
Walgreens Boots Alliance (WBA) Misses Q3 EPS by 8c, Cuts FY Guidance
June 27, 2023 7:01 AM EDT(Updated - June 27, 2023 7:03 AM EDT)
Walgreens Boots Alliance (NASDAQ: WBA) reported Q3 EPS of $1.00, $0.08 worse than the analyst estimate of $1.08. Revenue for the quarter came in at $35.4 billion versus the consensus estimate of $34.24 billion.
GUIDANCE:
Walgreens Boots Alliance sees... More



